相关实验视频
Updated: Jun 29, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
20.6K
在体内划分Jak2 V617F阳性MPN的Mpl依赖和Mpl独立表型
Nicolas Papadopoulos1, Audrey Nédélec2, Yacine Rahmani2
1de duve Institute, Belgium.
Blood
|May 7, 2025
概括
血栓形成素受体 (TpoR/MPL) 是至关重要的,但不仅仅是对Jak2 V617F驱动的骨髓增殖性瘤 (MPN) 负责. 在干细胞水平上抑制TpoR/MPL限制了突变克隆的优势.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 杰克2 V617F突变通过激活像TpoR.这样的细胞因子受体来驱动髓增殖性瘤 (MPNs).
- TpoR在造血干细胞的更新和分化中发挥着关键作用.
- 之前关于Jak2 V617F MPNs中TpoR/MPL缺失的研究使用了不反映自然基因调节的模型.
研究的目的:
- 通过使用一种新型小鼠模型,研究在Jak2 V617F驱动的MPN中TpoR/MPL缺失的体内作用.
- 为了划分由Jak2 V617F引起的Mpl-依赖和Mpl-独立的表型.
- 评估TpoR/MPL对克隆扩张和Jak2 V617F突变克隆的长期优势的影响.
主要方法:
- 在Mpl淘汰背景下在其内源性促进体下表达异合体Jak2 V617F的新型小鼠模型生成.
- 分析的表型包括红细胞瘤,白细胞瘤,壮症和纤维化.
- 评估了在竞争性移植中对造血原体种群和干细胞水平的生长刺激作用.
主要成果:
- 红细胞体,白细胞体和腹巨变在患有Jak2 V617F的Mpl缺乏小鼠中持续存在.
- 在早期的祖先中,Jak2 V617F诱导的生长刺激是一致的,但在没有Mpl.的干细胞水平上降低.
- 没有Mpl就会否定Jak2 V617F在干细胞水平上的长期克隆扩张优势.
结论:
- MPL是Jak2 V617F驱动的MPN的重要但不是唯一的贡献者.
- 杰克2 V617F诱导了Mpl依赖和Mpl独立的表型.
- 在干细胞水平上准MPL可以限制Jak2 V617F突变克隆的优势,提供治疗潜力.
相关概念视频
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...